February 2013 Issue

Toward More Accurate Diagnoses of Sarcomas

Researchers at North Carolina State University are hoping for a breakthrough in a study designed to distinguish spontaneous sarcomas from injection site-associated sarcomas (ISASs). Each year about 22,000 cats in the U.S. appear to develop sarcomas, or malignant tumors, at the site of a vaccination or other injection, according to the Morris Animal Foundation, which is funding the study. The more aggressive ISASs often recur. Identifying a sarcoma in its early stages “could provide crucial information to help guide the owner and veterinarian as the best approach to treatment, and in the longer term, help us to understand why these tumors occur,” says Rachael Thomas, Ph.D., leader of the research team

To continue reading this entire article you must be a paid subscriber.

Subscribe to CatWatch Newsletter

Which foods are really safe for your cat? How can you painlessly end furniture scratching---for good? What is your cat telling you when she refuses to eat? Get the answers to these questions- and many more- when you subscribe now to CatWatch!

Already subscribe but haven't registered for all the benefits of the website? Click here.

Subscriber Log In

Forgot your password? Click Here.